High-intensity focused ultrasound (HIFU) for the treatment of uterine fibroids: does HIFU significantly increase the risk of pelvic adhesions?

Xiaofang Liu, Xiaojing Dong, Yan Mu, Guohua Huang, Jia He, Lina Hu
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2020 · vol. 37(1) , pp. 1027–1032 · doi:10.1080/02656736.2020.1811903 · PMID:32873107 · W3082304729
article OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

OBJECTIVE: To investigate the prevalence of pelvic adhesions in patients with uterine fibroids after high-intensity focused ultrasound (HIFU) treatment, then analyze the influencing factors of pelvic adhesions. MATERIALS AND METHODS: From October 2010 to March 2020, a total of 2619 patients with uterine fibroids underwent either hysterectomy, myomectomy, or cesarean section in Suining Central Hospital of Sichuan province. Of the 2619 patients, 810 were excluded because of a documented history of either pelvic infections, endometriosis, prior abdominopelvic surgery, or gynecological malignancies; 1809 patients were enrolled and the data were retrospectively assessed for the prevalence and patterns of pelvic adhesions. Among them, 96 patients with uterine fibroids had had prior HIFU treatment (HIFU group), 1713 patients had not had HIFU or surgical treatments (control group). RESULTS: > .05). CONCLUSIONS: Based on our results with limited numbers, we concluded that HIFU treatment did not significantly increase the risk of pelvic adhesions.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Leiomyoma Leiomyoma Uterine Neoplasms Uterine Neoplasms Cesarean Section Female Humans Pregnancy Retrospective Studies Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (17)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:21:42.008780+00:00
License: CC0 · commercial use OK